Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Goldberg

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Nuclear Medicine|July 24, 2020
Acute Aortic Dissection Initially Suspected on 18F-FDG PET/CTGary A Ulaner, Stefan Muehlbauer, Zoe Goldberg
Frontiers in Allergy|November 17, 2022
Olfactory and neurological outcomes of SARS-CoV-2 from acute infection to recoveryDeesha D Desai, Sophie E Yu, Brock Salvatore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric CancerElizabeth Won, Azfar Basunia, Walid K Chatila, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
JAMA Network Open|February 2, 2023
Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract CancersBill H Diplas, Ryan Ptashkin, Joanne F Chou, et al.
Cancer|August 5, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomesParisa Momtaz, Catherine A O'Connor, Joanne F Chou, et al.
The Lancet. Oncology|September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trialSamuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|July 24, 2020
Acute Aortic Dissection Initially Suspected on 18F-FDG PET/CTGary A Ulaner, Stefan Muehlbauer, Zoe Goldberg
Frontiers in Allergy|November 17, 2022
Olfactory and neurological outcomes of SARS-CoV-2 from acute infection to recoveryDeesha D Desai, Sophie E Yu, Brock Salvatore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric CancerElizabeth Won, Azfar Basunia, Walid K Chatila, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
JAMA Network Open|February 2, 2023
Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract CancersBill H Diplas, Ryan Ptashkin, Joanne F Chou, et al.
Cancer|August 5, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomesParisa Momtaz, Catherine A O'Connor, Joanne F Chou, et al.
The Lancet. Oncology|September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trialSamuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.
Pageof 1